₹40.14
+0.00 (+0.00%)
As of 28 Aug 2026, Goldline Pharmaceutical Ltd share price is ₹40.14. The stock opened at ₹40.14 and had closed at ₹40.14 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹33.00 and a high of ₹60.00. In terms of performance, Goldline Pharmaceutical Ltd share price has decreased by 2.81% over the past six months and has decreased by 29.29% over the last year.
Goldline Pharmaceutical Charts
Goldline Pharmaceutical Ltd Overview
Market cap₹39 Crs
Volume3,000
Prev. Close₹40.14
Year range₹33.00 - ₹60.00
Total Value₹1,20,420.00
ISININE1CLW01015
About Goldline Pharmaceutical
Goldline Pharmaceutical are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.”
Goldline Pharmaceutical Ltd Historical Performance
1 Month Return4.61%
6 Month Return-
3 Year Return-
3 Month Return-8.67%
1 Year Return-
5 Year Return-
Goldline Pharmaceutical Ltd Fundamental Analysis
ROCE(TTM)28.35%
P/E Ratio (TTM)0.00
P/B Ratio1.60
Debt to Equity0.64
ROE28.89%
EPS (TTM)0.00
Dividend Yield0.00%
Book Value25.05
Profit Margin15.95%
Operating Margin0.00%
Goldline Pharmaceutical Ltd Financials
| Indicator | Mar 26 | Dec 25 |
|---|---|---|
| Revenue | - | - |
| EBITDA | - | - |
| Net Profit | 1.89 | 0.87 |
| EPS | 2.18 | 1.00 |
Goldline Pharmaceutical Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 47.53 |
| MACD | -0.35 |
| 20-Day SMA | 40.16 |
Goldline Pharmaceutical Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Goldline Pharmaceutical Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Goldline Pharmaceutical Ltd today is ₹40.14 on NSE and ₹40.14 on BSE.
- The 52-week high of Goldline Pharmaceutical Ltd is ₹60.00, while the 52-week low is ₹33.00.
- The current market capitalisation of Goldline Pharmaceutical Ltd is approximately ₹39 crore.
- The P/E (Price-to-Earnings) ratio of Goldline Pharmaceutical Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Goldline Pharmaceutical Ltd is 1.60. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Goldline Pharmaceutical Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Goldline Pharmaceutical Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Goldline Pharmaceutical Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Goldline Pharmaceutical Ltd comprises different categories of shareholders. As of May 2026, the shareholding is approximately 57.29% promoters, 5.16% FIIs, 7.81% DIIs, and 25.14% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
